Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > TLT.. NOT A ONE TRICK PONY
View:
Post by Tarbaby on Apr 05, 2024 1:14pm

TLT.. NOT A ONE TRICK PONY

Besides saving surgical bladder loss from cancer Dr. Mandel might change the whole cancer field with his version of immunotherapy. Vaccines for leukemia and blood cancers like lumphoma etc.
What is next..vaccines for solid tumours..?
Many congratulations to you Dr. GENIUS.
You are our hero..keep going please..!!
Comment by Eoganacht on Apr 05, 2024 1:22pm
It would be fantastic to see Theralase planning an actual trial for leukemia, lymphoma and/or myeloma using the vaccine. I hope this will soon be possible. 
Comment by managementfirst on Apr 05, 2024 1:59pm
cancer vaccine is pure imagination on unsolid base. wrong direction.
Comment by Kayz88 on Apr 05, 2024 5:21pm
I tend to agree, the idea sounds great in theory but introduces so many more variables into the equation:  1) It's a moonshot, we can barely afford to finish a phase 2 trial of bladder cancer  2) Our management team has issued something similar in the past with COVID vaccines, to no avail. Money was spent, no updates.  3) TLT is running with a handful of employees so I worry if ...more  
Comment by StevenBirch on Apr 05, 2024 7:36pm
If you were really paying attention they said during the zoom meeting they expect to hear something by the 3rd quarter on the Covid vaccine. Actually TLT seems to be able to multitask quite well unlike you who can't even handle bashing very well so to suggest BTD would take a backseat is....clueless? I can't think of a better way to decribe your comments sorry.
Comment by Kayz88 on Apr 05, 2024 7:50pm
I'm just raising my concerns...?
Comment by Alamir1111 on Apr 05, 2024 9:38pm
Theralase already benefits from a U.S. patent for PDC technology issued in October 2022, while a European Union patent is currently pending.
Comment by Pandora on Apr 06, 2024 1:08am
Assignment abstract of title for Application 16610991 Invention title/Inventor VACCINE CONTAINING CANCER CELLS INACTIVATED BY PHOTODYNAMIC TREATMENT WITH METAL-BASED COORDINATION COMPLEXES, AND IMMUNOTHERAPY METHOD USING SAME Arkady MANDEL Patent 11464798 Oct 11, 2022 Publication 20200222450 Jul 16, 2020 ...more  
Comment by DeathXray33 on Apr 06, 2024 8:17am
Exactly Birch. People tend to be extremely emotional and don't listen, or don't know how to listen and understand. I like to DCA 2 x a week; it works well since my crystal ball needs polishing. I'm sorry to sound like a broken record... Remember the Phonograph? What a great invention. Much better than the 8-track cartridge. There's just something "Cool" sounding about ...more  
Comment by menoalittle on Apr 06, 2024 8:47am
I've DCA'd so many times here I must have broken it.  Because it looks like it doesn't work for me anymore... lol.
Comment by Rumpl3StiltSkin on Apr 07, 2024 3:31pm
Would be great if this cancer vaccine leads to something Big. Soon too I hope.
Comment by steamfitter on Apr 08, 2024 11:25am
Vaccine  great to hear   What about the people that have cancer. 
Comment by DeathXray33 on Apr 08, 2024 11:37am
Are you serious? They use the patient's own cancer cells.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250